Related by context. All words. (Click for frequent words.) 68 olanzapine LAI 68 TEAEs 68 CANCIDAS 67 ARCALYST ® 67 adjunctive placebo 67 insulin detemir 67 APTIVUS r 66 salmeterol fluticasone 66 analgesic medications 66 PASI scores 66 #mg doses [002] 66 ALT flares 66 REYATAZ r arm 66 divalproex sodium 66 oral rivaroxaban 66 ketorolac 66 LATUDA 66 mg BID 66 oxycodone CR 65 INVEGA ® 65 treatment emergent adverse 65 intravenous bisphosphonates 65 mcg BID 65 solifenacin 65 tipranavir r 65 concomitant AEDs 65 NPH insulin 65 transaminase elevations 65 SCIg 65 symptom exacerbation 65 tolterodine ER 65 ATACAND 65 1mg dose 65 AGILECT R 65 Lipitor #mg 65 active comparator 65 salmeterol HFA MDI 65 events TEAEs 65 RLAI 65 tapentadol ER 65 PREZISTA r 65 mg eq 65 #mg/day [001] 64 mcg albinterferon alfa 2b 64 relapsed MM 64 receiving VICTRELIS 64 venlafaxine XR 64 mg ustekinumab 64 4mg/kg 64 severe exacerbations 64 idraparinux 64 transaminase elevation 64 achieved ACR# 64 TMC# r 64 hypoglycemic events 64 timepoints 64 gadobutrol 64 NATRECOR R 64 octreotide LAR 64 bolus dose 64 bezafibrate 64 nadroparin 64 lopinavir r arm 64 certolizumab 64 IV bisphosphonates 64 IOP lowering 64 inhaled fluticasone 64 canakinumab 64 5-FU/LV 64 tegaserod 64 mcg QD 63 lamotrigine 63 GSK# [001] 63 lopinavir r 63 oxcarbazepine 63 rFVIIa 63 reactogenicity 63 saline placebo 63 nadolol 63 rimonabant #mg 63 clomipramine 63 Engerix B 63 doxazosin 63 baseline HbA1c 63 amoxicillin clavulanate 63 levetiracetam 63 tipranavir ritonavir 63 8mg/kg 63 LPV r 63 #mg/day [002] 63 achieving PASI 63 tolvaptan 63 oral naltrexone 63 postintervention 63 TMP SMX 63 MADRS score 63 valacyclovir 63 QTc prolongation 63 imipenem 63 NNT = 63 lipid lowering agents 63 comparator arm 63 glargine 63 chlorambucil 63 virologic failure 63 ximelagatran 63 titrated glipizide 63 pegylated interferon alfa 63 zolmitriptan 63 β blockers 62 gastrointestinal toxicity 62 efalizumab 62 oral diclofenac 62 HBeAg seroconversion 62 intravenous cyclophosphamide 62 BoNTA 62 intravenous IV infusion 62 placebo dexamethasone 62 HBeAg negative patients 62 MIRAPEX 62 opioid naïve 62 unresectable HCC 62 Peripheral edema 62 guanfacine 62 NATRECOR ® 62 SSRI SNRI 62 eszopiclone 62 pamidronate 62 fosamprenavir 62 adjunctive ABILIFY 62 droperidol 62 desvenlafaxine succinate 62 CIMZIA TM certolizumab pegol 62 CIMZIA ™ 62 events AEs 62 moderate renal impairment 62 #mg dose [003] 62 Peg IFN 62 incidence ≥ 62 teriflunomide 62 BARACLUDE ® 62 abacavir lamivudine 62 events SAEs 62 PREZISTA rtv 62 severe hypersensitivity reactions 62 tiotropium 62 discontinuations due 62 fluoxetine paroxetine 62 tapentadol IR 62 EDSS scores 62 oral hypoglycemic agent 62 adalimumab 62 highly emetogenic 62 RAPTIVA 62 Perforomist Inhalation Solution 62 argatroban 62 oral vancomycin 62 FOLFOX4 62 PREZISTA ritonavir 62 venlafaxine 62 hematologic toxicity 62 pyridostigmine 62 tolterodine 62 FluCAM arm 62 CIMZIA TM 62 peginterferon 62 arterial thromboembolic events 61 JANUVIA 61 severe hypoglycaemia 61 oral Hycamtin 61 mycophenolate mofetil 61 thromboembolic events 61 morphometric vertebral fractures 61 nondiabetic patients 61 oxycodone IR 61 gout flare 61 lispro 61 tolerability profiles 61 unfractionated heparin UFH 61 fluticasone salmeterol 61 laboratory abnormalities 61 lacosamide 61 PegIFN RBV 61 CAELYX 61 glycated hemoglobin levels 61 dexmedetomidine 61 receiving ISENTRESS 61 Lamictal XR 61 insulin degludec 61 subcutaneous enoxaparin 61 ibandronate 61 elevated ALT 61 PEG Intron 61 prednisone prednisolone 61 FROVA 61 ARIXTRA 61 Flu Cy 61 Viread Emtriva 61 COPD exacerbation 61 mg kg dose 61 antiepileptics 61 paliperidone ER 61 bupropion SR 61 administered subcutaneously 61 Pegasys peginterferon alfa 2a 61 idarubicin 61 antiepileptic medications 61 typical antipsychotics 61 metformin monotherapy 61 hypoglycaemic episodes 61 peginterferon alfa 2a 61 inhaled anticholinergics 61 biphasic insulin aspart 61 atorvastatin #mg 61 protease inhibitor PI 61 alpha interferons 61 PRISTIQ 61 tamsulosin 61 interferon alfa 2b 61 KAPIDEX 61 quetiapine 61 recurrent genital herpes 61 ZOMIG 61 mg Proellex 61 mesalamine granules 61 fluvastatin 61 ddI 61 tigecycline 61 mcg dose 61 risperidone olanzapine 61 antiepileptic drugs AEDs 61 adriamycin 61 Adverse events 61 prucalopride 61 VaD 61 nevirapine Viramune 61 oral prednisone 61 co trimoxazole 61 OADs 61 Treatment emergent adverse 60 Baseline characteristics 60 Zavesca R 60 pramipexole 60 EXJADE 60 GnRH agonist 60 #mg dose [002] 60 TNF inhibitor 60 systemic corticosteroid 60 tranylcypromine 60 TDF FTC 60 pegylated liposomal doxorubicin 60 polytherapy 60 ACTEMRA TM 60 vasomotor symptoms 60 placebo controlled trials 60 3mg/kg 60 peginterferon alfa 60 neutropenia dehydration dyspnea 60 alemtuzumab treated 60 terazosin 60 amphotericin B 60 ritonavir boosted protease inhibitor 60 unstable angina pectoris 60 mg administered orally 60 SPIRIVA HandiHaler 60 primidone 60 aminotransferase elevations greater 60 clinically meaningful reductions 60 mcg Albuferon 60 Oral corticosteroids 60 glyburide 60 rizatriptan 60 LEXIVA r 60 Febrile neutropenia 60 prolonged QT interval 60 symptomatic VTE 60 ARCOXIA 60 timepoint 60 LEXIVA 60 endoscopic remission 60 adefovir treated 60 myopathy rhabdomyolysis 60 anthracycline taxane 60 sotalol 60 biologic DMARD 60 Doxil ® 60 tacrolimus ointment 60 VIIBRYD 60 leukopenia 60 galiximab 60 EFFEXOR XR 60 dopamine partial agonist 60 virologically 60 placebo controlled studies 60 intravitreal injections 60 Avandia Actos 60 BYSTOLIC 60 virologic breakthrough 60 TNF antagonist 60 achieved statistical significance 60 reinfarction 60 thrombocytopenic 60 FOLPI 60 definite stent thrombosis 60 candidemia 60 neuroleptics 60 AZT zidovudine Retrovir 60 serum phosphate levels 60 quetiapine risperidone 60 low dose cytarabine 60 isoproterenol 60 caspofungin 60 intravenous morphine 60 glatiramer acetate 60 incontinence episodes 60 IV bolus 60 beta blocker therapy 60 metformin HCl 60 dose colchicine 60 clinically meaningful improvements 60 Raptiva r 60 antiretroviral naive 60 octreotide acetate 60 aripiprazole 60 DOXIL 60 ethambutol 60 lopinavir ritonavir 60 virologic response 60 mg simvastatin 60 experienced virologic failure 60 DETROL LA 60 oral levofloxacin 60 eplerenone 60 pegylated interferon alpha 60 NNRTI resistance 60 doripenem 60 levofloxacin 60 efavirenz EFV 60 bovine thrombin 60 HIV HCV coinfected 60 nonvertebral fracture 60 fluticasone furoate 60 EDARBI 60 limiting toxicity 60 unfractionated heparin 60 digoxin toxicity 60 PROCRIT 60 atazanavir ritonavir 60 overlapping toxicities 60 PRADAXA #mg 60 darunavir ritonavir 60 risperidone Risperdal 60 Pentacel vaccine 60 infliximab therapy 60 palonosetron 60 Keppra R 60 tenofovir emtricitabine 60 ULORIC 60 ribavirin RBV 60 anakinra 60 ritonavir boosted atazanavir 60 Epivir 59 Veramyst 59 clodronate 59 achieved PASI 59 ziprasidone 59 oral corticosteroid 59 pegaptanib 59 DLTs 59 subcutaneous insulin 59 low dose Iluvien 59 #mg ATC 59 rilpivirine 59 antiarrhythmic drug 59 anemia hemoglobin 59 COPEGUS 59 Quetiapine 59 oral alendronate 59 High Dose quadruples 59 Fulvestrant 59 discontinuations 59 Lantus ® 59 LNG IUS 59 UPDRS motor 59 IgG isotype 59 pegylated interferon alfa 2b 59 sumatriptan naproxen sodium 59 #mg dose [001] 59 ribavirin therapy 59 fluconazole 59 ziconotide 59 decitabine 59 ZYVOX 59 dalteparin 59 micafungin 59 intravenous diuretics 59 moderately emetogenic 59 clevidipine 59 SSRI antidepressant 59 rosuvastatin #mg 59 FOSRENOL ® 59 Paxil paroxetine 59 acute gout flares 59 #mg BID [001] 59 microgram kg 59 intravenous vancomycin 59 hematologic adverse 59 mg dose 59 docetaxel chemotherapy 59 divalproex 59 IR prednisone 59 cabazitaxel 59 peginterferon alfa 2b 59 IFN beta 59 ZOMIG Nasal Spray 59 mitoxantrone plus 59 haematologic 59 VELCADE melphalan 59 posaconazole 59 serum urate levels 59 FOLFIRI 59 HbA 1c levels 59 Torsades de Pointes 59 Pegasys ® 59 mg kg intravenously 59 insulin lispro 59 bolus injection 59 conventional DMARDs 59 Navelbine 59 aldosterone antagonist 59 IBS C 59 mg doses 59 venlafaxine ER 59 serum phosphorous 59 rifabutin 59 STELARA ™ 59 ug kg 59 patients evaluable 59 Adverse reactions 59 Aptivus ® 59 ketoconazole 59 zidovudine lamivudine 59 metformin sulfonylurea 59 ocular inflammation 59 valdecoxib 59 Stent thrombosis 59 #mg BID [003] 59 Pioglitazone 59 macrolide antibiotic 59 Infusion Reactions Severe 59 pooled comparator 59 stavudine d4T 59 dose escalation phase 59 EMEND 59 drug eluting stent implantation 59 recurrent glioblastoma multiforme 59 melphalan prednisone 59 rHuEPO 59 steroid dexamethasone 59 lenalidomide dexamethasone 59 Non inferiority 59 CYPHER Stent 59 KRAS mutant tumors 59 paroxetine Paxil 59 thromboembolic complications 59 Pharmacokinetic parameters 59 azacitidine 59 symptomatic hypotension 59 ritonavir boosted lopinavir 59 methotrexate monotherapy 59 receiving VELCADE 59 doxorubicin cyclophosphamide 59 ONGLYZA 59 pyrexia mucositis sepsis febrile 59 rilonacept 59 tipranavir 59 β blocker 59 inactive placebo 59 gemifloxacin 59 invasive candidiasis 59 GERD symptom 59 intravenous bolus injection 59 receiving XGEVA 59 oral antidiabetes 59 VIRAMUNE XR 59 conventional antipsychotics 59 fibrinolytic therapy 59 cilostazol 59 Navelbine ® 59 glimepiride 59 dapagliflozin plus 59 plus methotrexate 59 relapsed SCLC 59 flutamide 59 LHRH agonists 59 ARICEPT 59 hypercholesterolemic patients 59 inecalcitol 59 Elitek 59 Tekamlo 59 severe renal impairment 59 lenalidomide Revlimid R 59 INVEGA ® SUSTENNA TM 59 naïve HCV 59 NIASPAN 59 MMRV vaccine 59 HBeAg positive patients 59 ancrod 59 fasting triglyceride levels 59 indinavir 59 non selective NSAIDs 59 KETEK 59 postmenopausal osteoporotic women 59 serum urate 59 linaclotide treated 59 vinorelbine 59 locoregional recurrence 59 inhaled bronchodilator 59 liver transaminases 59 ocular adverse 59 cidofovir 59 olanzapine 59 dacarbazine chemotherapy 59 mitoxantrone 59 sitagliptin 59 rosuvastatin Crestor 59 ß blockers 58 CHOP chemotherapy 58 monoamine oxidase inhibitors MAOIs 58 FFNS 58 hypokalemia 58 intracranial hemorrhage ICH 58 INVEGA R 58 timolol 58 TAXOTERE ® 58 cerebrovascular events 58 MMSE score 58 dacarbazine DTIC 58 revascularizations 58 nelfinavir 58 infliximab Remicade 58 dosage regimens 58 captopril 58 adverse reactions incidence 58 Ramipril 58 XEPLION R 58 acute HAE attacks 58 pimecrolimus 58 Toxicities 58 antiretroviral naïve 58 quetiapine XR 58 placebo intravenously 58 Perforomist TM Inhalation Solution 58 dose atorvastatin 58 Known hypersensitivity 58 intravitreal injection 58 Lucentis monotherapy 58 aspirin clopidogrel 58 INCB# [003] 58 CR nPR 58 MoxDuo TM IR 58 oxymorphone ER 58 budesonide formoterol 58 GnRH agonists 58 hsCRP levels 58 mild renal insufficiency 58 inhaled budesonide 58 renal toxicity 58 ARB telmisartan 58 placebo 58 prospectively stratified 58 boosted protease inhibitor 58 carbidopa 58 MACUGEN 58 Revascor TM 58 antiarrhythmic drugs 58 amisulpride 58 epoetin alfa 58 oral antidiabetic agents 58 mg/m2 dose 58 AVELOX 58 systemic corticosteroids 58 amenorrhoea 58 KRAS mutations occur 58 serum creatinine levels 58 dosing interval 58 comorbid ADHD 58 HbA1C levels 58 mirtazapine 58 Certolizumab pegol 58 Atacand 58 constipation nausea 58 endothelin receptor antagonists 58 placebo controlled clinical trials 58 antiemetics 58 MCyR 58 coinfected patients 58 maximal doses 58 alteplase 58 Fludara 58 PEGINTRON TM 58 CK # administered 58 antimuscarinic 58 pioglitazone Actos 58 HBeAg positive 58 mcg doses 58 invasive fungal infection 58 AGILECT ® 58 SUSTIVA 58 quinine sulfate 58 interferon ribavirin 58 anemia neutropenia 58 INVEGA ™ 58 Apidra ® 58 #.#g/day 58 intravenous dosing 58 TYSABRI treated 58 dosing cohort 58 inhaled iloprost 58 triptan 58 CONCERTA 58 rotigotine 58 tamoxifen Nolvadex ® 58 TPV r 58 INVEGA SUSTENNA 58 FASLODEX 58 tricyclic antidepressants 58 ACTOplus met XR 58 achieved CCyR 58 oral antidiabetic medication 58 deferoxamine 58 iodixanol 58 zonisamide SR 58 SEROQUEL XR 58 ALIMTA cisplatin 58 ARCALYST 58 pioglitazone HCl 58 urate lowering therapy 58 dosing intervals 58 RLS symptoms 58 NUCYNTA ® 58 paresthesias 58 headache nasopharyngitis 58 glulisine 58 AVODART 58 seroprotection 58 pegylated interferon alfa 2a 58 ciclesonide 58 fluoxetine Prozac 58 mg XP# 58 oxybutynin 58 antiepileptic drug 58 carotid artery blockage 58 attain statistical significance 58 recurrent ischemia 58 administered intranasally 58 de novo kidney transplant 58 EQUETRO 58 INFERGEN 58 budesonide pMDI 58 insulin glargine 58 macroalbuminuria 58 STELARA ® 58 neutropaenia 58 APRISO 58 mg subcutaneously 58 Hypersensitivity reactions 58 affective psychosis 58 dose regimens 58 hemorrhagic complications 58 selegiline 58 ropivacaine 58 symptomatic hyponatremia 58 gatifloxacin 58 myelosuppression 58 Desferal 58 induce orthostatic hypotension 58 recurrent VTE 58 plus OBT 58 prednisone prednisolone plus 58 p = NS 58 mCRC acneform rash 58 enalapril 58 acarbose 58 carboplatin paclitaxel 58 gross hematuria 58 dexamethasone Decadron 58 transdermal estradiol 58 lipid parameters 58 oral antidiabetes drugs 58 maximally tolerated dose 58 oral FTY# 58 infliximab monotherapy 58 aldosterone antagonists 58 goserelin 58 Study GL# 58 TNF alpha inhibitor 58 mg Pycnogenol 58 anticoagulant warfarin 58 perioperatively 58 neutropenia thrombocytopenia 58 extrapyramidal symptoms 58 venlafaxine Effexor 58 piperacillin tazobactam 58 interferon beta therapy 58 headache abdominal pain 58 trospium 58 syncopal 58 RISPERDAL ® 58 NovoLog ® Mix 58 guanfacine extended release 58 pharmacokinetic characteristics 58 REMINYL ® 58 ULTRAM ER 58 sitaxsentan 58 lanthanum carbonate 58 monoinfected patients 58 antihypertensive drugs 58 retinal vein occlusion 58 TYGACIL 58 ISENTRESS 58 AZILECT 58 Sinemet 58 euthymic patients 58 non hematological toxicities 58 carbidopa levodopa 58 DMARDS 58 treprostinil 58 benazepril 58 TNF antagonists 58 dose corticosteroids 58 uridine triacetate 58 Remicade infliximab 58 esomeprazole 58 LEVAQUIN ® 58 Proleukin 58 Capecitabine 58 sulfasalazine 58 daunorubicin 58 MIRAPEX ER 58 sulphonylureas 58 Cimzia R 58 diuretic chlorthalidone 58 pegylated interferons 58 treatment emergent AEs 58 lumbar spine BMD 58 uric acid lowering 58 prazosin 58 peginterferon alpha 2a 58 PREZISTA r arm 58 intravenous bolus 58 Cariprazine 58 hepatorenal syndrome 58 Traficet EN 58 bisoprolol 58 ALVESCO 58 beclomethasone dipropionate 58 #.#mg/dL 58 methimazole 58 aprepitant 58 intra articular injection 58 detectable HCV RNA 58 periprocedural 57 telaprevir dosing 57 antiandrogen 57 LT NS# 57 buprenorphine naloxone 57 systemic immunosuppressive 57 lymphopenia 57 milrinone 57 maximal tolerated 57 CCyR 57 inert placebo 57 trials RCTs 57 FUSILEV enhances 57 leukotriene receptor antagonists 57 eosinophilic asthma 57 mg TID 57 dopamine receptor agonist 57 Hepatotoxicity 57 parecoxib 57 ritonavir boosted 57 angiographic outcomes 57 quinidine 57 Lupuzor ™ 57 VAPRISOL 57 extrapyramidal disorder 57 squamous histology 57 retrograde ejaculation 57 nicardipine 57 riociguat 57 balsalazide 57 folinic acid 57 Lantus R 57 acetaminophen codeine 57 triamcinolone 57 nebulized formoterol fumarate 57 oral corticosteroids 57 recurrent atrial fibrillation 57 juvenile idiopathic arthritis JIA 57 glitazone 57 elevated LDH 57 DMARD 57 ARIMIDEX 57 Betaferon ® 57 REYATAZ R 57 serum calcium levels 57 aminotransferases 57 hemorrhagic cystitis 57 tocilizumab 57 % CI #.#-#.# [003] 57 doxorubicin docetaxel 57 methotrexate therapy 57 somnolence dizziness 57 REYATAZ 57 abacavir Ziagen 57 undetectable viral 57 hemoglobin A1c levels 57 beta carotene supplementation 57 corticosteroid therapy 57 NEUPOGEN 57 chlorthalidone 57 asthma exacerbations 57 Neurodex 57 placebo p = 57 glycopyrrolate 57 KADIAN ® 57 ceftriaxone 57 azathioprine 57 serum potassium 57 detemir 57 pharmacokinetic interactions 57 elevated serum creatinine 57 severe hypoglycemic 57 antidepressants fluoxetine 57 partial remissions 57 acitretin 57 mcg kg 57 subcutaneously injected 57 anticholinergics 57 oral anticoagulation 57 BENICAR HCT 57 dosing cohorts 57 zafirlukast 57 etanercept 57 alfa 2a 57 clobazam 57 valproate 57 mg tid 57 PegIntron 57 hematological toxicity 57 clot busting therapy 57 calcineurin inhibitor 57 OAB symptoms 57 prospectively enrolled 57 infusional 57 FOLPI regimen 57 myoclonic seizures 57 alanine aminotransferase 57 oral allopurinol 57 glatiramer 57 hepatotoxicity 57 hypertensives 57 prescribed opioids 57 alpha blocker 57 mg/# h 57 1mg 2mg 57 Butrans 57 montelukast 57 APTIVUS R 57 palivizumab 57 serum phosphate 57 angiographic restenosis 57 IFN alfa 57 Q2W 57 AA Amyloidosis 57 enfuvirtide 57 visilizumab 57 inhaled glucocorticoids 57 Metoprolol 57 oral antidiabetic drugs 57 INVEGA 57 vWD 57 adefovir 57 thromboembolic 57 weekly intravenous infusions 57 nortriptyline 57 generalized edema 57 heparin induced thrombocytopenia 57 corticosteroid dose 57 paliperidone 57 ticlopidine 57 venous thromboembolisms 57 UPDRS scores 57 antithrombotics 57 pimozide 57 LOVENOX R 57 preintervention 57 demonstrated antitumor activity 57 postoperative chemotherapy 57 + PH# 57 COPAXONE R 57 dose titration 57 maximally tolerated lipid lowering 57 antifibrinolytic 57 MYCAMINE 57 delayed CINV 57 d4T 57 anagrelide 57 rimonabant #mg/day 57 paclitaxel eluting stents 57 neurologic complications 57 sertraline Zoloft 57 PREMPRO 57 neutrophil counts 57 dysmenorrhoea 57 RoACTEMRA 57 hypercholesterolaemia 57 paliperidone palmitate 57 nonrandomized 57 acute bipolar mania 57 asthma exacerbation 57 plus dexamethasone 57 rhGH 57 ORENCIA ® 57 virological failure 57 sodium valproate 57 concomitant medications 57 Bicalutamide 57 Taxotere R 57 Adalimumab 57 dose cohort 57 pegylated IFN 57 continuous intravenous infusion 57 MAS XR 57 interferon alfa 57 pioglitazone 57 Durezol 57 linear pharmacokinetics 57 Natalizumab 57 Pramipexole 57 deletion 5q 57 PULMICORT RESPULES 57 nonfatal MI 57 postdose 57 PROCRIT ® 57 HbA1c levels 57 NUCYNTA R 57 olmesartan 57 tramadol acetaminophen 57 ABC/3TC 57 somatostatin analog 57 piroxicam 57 paricalcitol 57 antibiotic rifaximin 57 lipid lowering therapy 57 HMG CoA reductase inhibitors 57 severe neutropenia 57 paroxysmal AF 57 MEVACOR 57 dopaminergic therapy 57 hypofractionated radiation 57 ABILIFY Injection 57 TOVIAZ 57 fluticasone 57 PREMARIN Vaginal Cream 57 gemcitabine cisplatin 57 ascending dose 57 FDA defined valvulopathy 57 haloperidol Haldol 57 Hypotension 57 thromboprophylaxis 57 plus prednisone prednisolone 57 anaphylactoid reactions 57 EDSS score 57 rufinamide 57 azelastine 57 clopidogrel Plavix 57 VFEND 57 ACE inhibitor ramipril 57 Abilify aripiprazole 57 allergen immunotherapy 57 Seroquel quetiapine fumarate 57 blind placebo 57 atorvastatin Lipitor 57 FIRMAGON 57 COREG 57 APTIVUS ritonavir 57 azoospermia 57 aspartate aminotransferase AST 57 ispinesib administered 57 Diovan HCT 57 Erythropoietic therapies may 57 ACTOplus met 57 latrepirdine 57 Immune reconstitution syndrome 57 atazanavir 57 invasive aspergillosis 57 diabetic neuropathic pain